To identify novel candidate molecules, Dufva and colleagues carried out a high-throughput drug screen using a coculture assay with CD19-directed CAR T cells in presence of the CD19-positive B-ALL cell line, NALM6. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.